Search Results - "ALPERT, E"

Refine Results
  1. 1

    Pharmacological approaches to the challenge of treatment-resistant depression by Ionescu, Dawn F., Rosenbaum, Jerrold F., Alpert, Jonathan E.

    Published in Dialogues in clinical neuroscience (01-06-2015)
    “…Although monoaminergic antidepressants revolutionized the treatment of Major Depressive Disorder (MDD) over a half-century ago, approximately one third of…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Monitoring Changes in Depression Severity Using Wearable and Mobile Sensors by Pedrelli, Paola, Fedor, Szymon, Ghandeharioun, Asma, Howe, Esther, Ionescu, Dawn F, Bhathena, Darian, Fisher, Lauren B, Cusin, Cristina, Nyer, Maren, Yeung, Albert, Sangermano, Lisa, Mischoulon, David, Alpert, Johnathan E, Picard, Rosalind W

    Published in Frontiers in psychiatry (18-12-2020)
    “…While preliminary evidence suggests that sensors may be employed to detect presence of low mood it is still unclear whether they can be leveraged for measuring…”
    Get full text
    Journal Article
  4. 4

    TRANSITION-REGION/CORONAL SIGNATURES AND MAGNETIC SETTING OF SUNSPOT PENUMBRAL JETS: HINODE (SOT/FG), Hi-C, AND SDO/AIA OBSERVATIONS by Tiwari, Sanjiv K., Moore, Ronald L., Winebarger, Amy R., Alpert, Shane E.

    Published in The Astrophysical journal (10-01-2016)
    “…ABSTRACT Penumbral microjets (PJs) are transient narrow bright features in the chromosphere of sunspot penumbrae, first characterized by Katsukawa et al. using…”
    Get full text
    Journal Article
  5. 5

    Coral Sr‐U thermometry by DeCarlo, Thomas M., Gaetani, Glenn A., Cohen, Anne L., Foster, Gavin L., Alpert, Alice E., Stewart, Joseph A.

    Published in Paleoceanography (01-06-2016)
    “…Coral skeletons archive past climate variability with unrivaled temporal resolution. However, extraction of accurate temperature information from coral…”
    Get full text
    Journal Article
  6. 6

    Hi-C OBSERVATIONS OF SUNSPOT PENUMBRAL BRIGHT DOTS by Alpert, Shane E., Tiwari, Sanjiv K., Moore, Ronald L., Winebarger, Amy R., Savage, Sabrina L.

    Published in The Astrophysical journal (01-05-2016)
    “…ABSTRACT We report observations of bright dots (BDs) in a sunspot penumbra using High Resolution Coronal Imager (Hi-C) data in 193 and examine their sizes,…”
    Get full text
    Journal Article
  7. 7

    A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment by FAVA, Maurizio, GRAVES, Lesley M, BENAZZI, Franco, SCALIA, Margaret J, IOSIFESCU, Dan V, ALPERT, Jonathan E, PAPAKOSTAS, George I

    Published in The journal of clinical psychiatry (01-11-2006)
    “…Antidepressant therapies have been associated with a variety of side effects of both physical and psychological nature. Until recently, however, the majority…”
    Get full text
    Journal Article
  8. 8

    Ocular neuroprotection by siRNA targeting caspase-2 by Ahmed, Z, Kalinski, H, Berry, M, Almasieh, M, Ashush, H, Slager, N, Brafman, A, Spivak, I, Prasad, N, Mett, I, Shalom, E, Alpert, E, Di Polo, A, Feinstein, E, Logan, A

    Published in Cell death & disease (01-06-2011)
    “…Retinal ganglion cell (RGC) loss after optic nerve damage is a hallmark of certain human ophthalmic diseases including ischemic optic neuropathy (ION) and…”
    Get full text
    Journal Article
  9. 9

    Frontal EEG predictors of treatment outcome in major depressive disorder by Iosifescu, Dan V, Greenwald, Scott, Devlin, Philip, Mischoulon, David, Denninger, John W, Alpert, Jonathan E, Fava, Maurizio

    Published in European neuropsychopharmacology (01-11-2009)
    “…Abstract Objective To investigate the role of frontal EEG as predictor of clinical response to SSRIs or venlafaxine in major depressive disorder (MDD). Method…”
    Get full text
    Journal Article
  10. 10

    Monoamine Oxidase A and Catechol-O-Methyltransferase Functional Polymorphisms and the Placebo Response in Major Depressive Disorder by LEUCHTER, Andrew F, MCCRACKEN, James T, HUNTER, Aimee M, COOK, Ian A, ALPERT, Jonathan E

    Published in Journal of clinical psychopharmacology (01-08-2009)
    “…The placebo response shows pronounced interindividual variability. Placebos are postulated to act through central reward pathways that are modulated by…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder by PAPAKOSTAS, George I, PETERSEN, Timothy J, KINRYS, Gustavo, BURNS, Alana M, WORTHINGTON, John J, ALPERT, Jonathan E, FAVA, Maurizio, NIERENBERG, Andrew A

    Published in The journal of clinical psychiatry (01-10-2005)
    “…Due to their favorable side effect profile, atypical antipsychotic agents offer important therapeutic advantages in mood disorders. Aripiprazole, an atypical…”
    Get full text
    Journal Article
  14. 14

    Timing of Onset of Antidepressant Response With Fluoxetine Treatment by Nierenberg, Andrew A., Farabaugh, Amy H., Alpert, Jonathan E., Gordon, Johanna, Worthington, John J., Rosenbaum, Jerrold F., Fava, Maurizio

    Published in The American journal of psychiatry (01-09-2000)
    “…OBJECTIVE: The purpose of this study was to assess the time until onset of antidepressant response with fluoxetine treatment. METHOD: The authors evaluated 182…”
    Get full text
    Journal Article
  15. 15

    Predictors of Relapse in a Prospective Study of Fluoxetine Treatment of Major Depression by McGrath, Patrick J., Stewart, Jonathan W., Quitkin, Frederic M., Chen, Ying, Alpert, Jonathan E., Nierenberg, Andrew A., Fava, Maurizio, Cheng, Jianfeng, Petkova, Eva

    Published in The American journal of psychiatry (01-09-2006)
    “…Objective: Loss of response to a previously effective antidepressant is a common clinical problem. Retrospective analyses have shown that the pattern of…”
    Get full text
    Journal Article
  16. 16

    Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder by PAPAKOSTAS, George I, PETERSEN, Timothy J, NIERENBERG, Andrew A, MURAKAMI, Jessica L, ALPERT, Jonathan E, ROSENBAUM, Jerrold F, FAVA, Maurizio

    Published in The journal of clinical psychiatry (01-02-2004)
    “…Due to their favorable side-effect profile, atypical antipsychotic agents offer important therapeutic advantages in mood disorders. Ziprasidone, an atypical…”
    Get full text
    Journal Article
  17. 17

    The Impact of Medical Comorbidity on Acute Treatment in Major Depressive Disorder by Iosifescu, Dan V., Nierenberg, Andrew A., Alpert, Jonathan E., Smith, Megan, Bitran, Stella, Dording, Christina, Fava, Maurizio

    Published in The American journal of psychiatry (01-12-2003)
    “…OBJECTIVE: The authors investigated the impact of medical comorbidity on the acute phase of antidepressant treatment in subjects with major depressive…”
    Get full text
    Journal Article
  18. 18

    Mid‐Holocene, Coral‐Based Sea Surface Temperatures in the Western Tropical Atlantic by Rodriguez, Luis G., Cohen, Anne L., Ramirez, Wilson, Oppo, Delia W., Pourmand, Ali, Edwards, R. Lawrence, Alpert, Alice E., Mollica, Nathaniel

    Published in Paleoceanography and paleoclimatology (01-07-2019)
    “…The Holocene is considered a period of relative climatic stability, but significant proxy data‐model discrepancies exist that preclude consensus regarding the…”
    Get full text
    Journal Article
  19. 19

    Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STARD by Fava, Maurizio, Alpert, Jonathan E, Carmin, Cheryl N, Wisniewski, Stephen R, Trivedi, Madhukar H, Biggs, Melanie M, Shores-Wilson, Kathy, Morgan, Don, Schwartz, Terry, Balasubramani, G K, Rush, A John

    Published in Psychological medicine (01-10-2004)
    “…Anxious depression, defined as Major Depressive Disorder (MDD) with high levels of anxiety symptoms, may represent a relatively common depressive subtype, with…”
    Get more information
    Journal Article
  20. 20

    A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder by Mischoulon, David, Best-Popescu, Catherine, Laposata, Michael, Merens, Wendelien, Murakami, Jessica L, Wu, Shirley L, Papakostas, George I, Dording, Christina M, Sonawalla, Shamsah B, Nierenberg, Andrew A, Alpert, Jonathan E, Fava, Maurizio

    Published in European neuropsychopharmacology (01-09-2008)
    “…Abstract We examined the antidepressant efficacy and dose–response pattern of the n −3 docosahexaenoic acid (DHA). Thirty-five depressed adult outpatients (46%…”
    Get full text
    Journal Article